Synex Consulting Korea Ltd.   Report issue

For profit Phase 1
Founded: Seoul Korea, Republic of (2002)

Organization Overview

First Clinical Trial
2012
NCT01689220
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now